Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire M Edwards

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Molecular Cancer Therapeutics|December 11, 2007
Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosisRachel M Locklin, Ermanno Federici, Belen Espina, et al.
Plos One|November 23, 2012
Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cellsJunling Zhuang, Jianghong Zhang, Seint T Lwin, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 7, 2007
Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductaseAnke J Roelofs, Claire M Edwards, R Graham G Russell, et al.
Scientific Reports|August 28, 2019
Small Animal Video Tracking for Activity and Path Analysis Using a Novel Open-Source Multi-Platform Application (AnimApp)Srinivasa R Rao, Sam W Z Olechnowicz, Patrick Krätschmer, et al.
Haematologica|February 12, 2026
High-cholesterol diet fuels myeloma progression, dysregulates adipokine expression <i>in vivo</i>, and impairs treatment response <i>ex vivo</i>Beatriz Gámez, Danielle J Whipp, Srinivasa R Rao, et al.
American Journal of Hematology|March 20, 2009
Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivoClaire M Edwards, Seint T Lwin, Jessica A Fowler, et al.
JACS Au|November 30, 2023
Antibody-Based Imaging of Bioreductive Prodrug Release in HypoxiaÇağla Tosun, Antoine L D Wallabregue, Maxim Mallerman, et al.
Frontiers in Oncology|April 2, 2020
Transcriptomic and Functional Screens Reveal MicroRNAs That Modulate Prostate Cancer MetastasisSrinivasa R Rao, Alison Howarth, Patrick Kratschmer, et al.
Blood|September 13, 2011
Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone diseaseJessica A Fowler, Seint T Lwin, Matthew T Drake, et al.
Translational Oncology|December 10, 2021
The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivoBeatriz Gámez, Emma V Morris, Sam W Z Olechnowicz, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Molecular Cancer Therapeutics|December 11, 2007
Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosisRachel M Locklin, Ermanno Federici, Belen Espina, et al.
Plos One|November 23, 2012
Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cellsJunling Zhuang, Jianghong Zhang, Seint T Lwin, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 7, 2007
Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductaseAnke J Roelofs, Claire M Edwards, R Graham G Russell, et al.
Scientific Reports|August 28, 2019
Small Animal Video Tracking for Activity and Path Analysis Using a Novel Open-Source Multi-Platform Application (AnimApp)Srinivasa R Rao, Sam W Z Olechnowicz, Patrick Krätschmer, et al.
Haematologica|February 12, 2026
High-cholesterol diet fuels myeloma progression, dysregulates adipokine expression <i>in vivo</i>, and impairs treatment response <i>ex vivo</i>Beatriz Gámez, Danielle J Whipp, Srinivasa R Rao, et al.
American Journal of Hematology|March 20, 2009
Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivoClaire M Edwards, Seint T Lwin, Jessica A Fowler, et al.
JACS Au|November 30, 2023
Antibody-Based Imaging of Bioreductive Prodrug Release in HypoxiaÇağla Tosun, Antoine L D Wallabregue, Maxim Mallerman, et al.
Frontiers in Oncology|April 2, 2020
Transcriptomic and Functional Screens Reveal MicroRNAs That Modulate Prostate Cancer MetastasisSrinivasa R Rao, Alison Howarth, Patrick Kratschmer, et al.
Blood|September 13, 2011
Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone diseaseJessica A Fowler, Seint T Lwin, Matthew T Drake, et al.
Translational Oncology|December 10, 2021
The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivoBeatriz Gámez, Emma V Morris, Sam W Z Olechnowicz, et al.
Pageof 6